Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 57 clinical trials
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

anticoagulation therapy. Apixaban may help in prevention by blocking some of the enzymes needed for venous thrombosis.

anticoagulant therapy
metastasis
anticoagulation therapy
primary cancer
cancer
  • 121 views
  • 27 Jan, 2021
  • 38 locations
Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy

Guidelines recommended that patients with bioprosthetic heart valves (BHV) only need 6 months oral anticoagulation therapy after operation. However, a small part of patients still suffered

  • 0 views
  • 23 Jan, 2021
  • 1 location
Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer

The primary purpose of this study is to determine the optimal duration of anticoagulation therapy (6 months versus 18 months) with direct oral anticoagulant (DOAC) for cancer-associated low-risk

  • 0 views
  • 02 Mar, 2021
  • 1 location
Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation

Patients will be screened at Intermountain Medical Center and at Intermountain-affiliated anticoagulation clinics in the Salt Lake City region. Patients with non-valvular atrial fibrillation will be considered for study. After written informed consent is obtained, subjects who meet eligibility criteria will be randomized 1:1 to 2 treatment arms: Group 1: …

cognitive assessment
vascular disease
cognitive decline
dementia
  • 58 views
  • 22 Jan, 2021
  • 1 location
Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

The objective of the study is to compare short-term (8 weeks) anticoagulation therapy (DOAC) vs. antiplatelet therapy for the prevention of device thrombosis following transcatheter LAAC

dabigatran
antiplatelet therapy
anticoagulation therapy
apixaban
aspirin
  • 10 views
  • 23 Jan, 2021
  • 1 location
OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in Hemodialysis

A randomised, prospective, cross over study will be done to determine whether the anticoagulation therapy with UFH or LMWH used for hemodialysis sessions modifies osteoprotegerin and

heparin
  • 9 views
  • 07 Nov, 2020
  • 1 location
Impact of the CareLink Express Remote Monitoring System on Early Detection of Atrial Fibrillation

strategy in patients at high risk of thromboembolic events, e.g. anticoagulation therapy onset, electrical cardioversion or/and PVI.

fibrillation
anticoagulation therapy
cardioversion
thromboembolism
  • 0 views
  • 24 Jan, 2021
  • 1 location
Comparison of Citrate and Heparin Anticoagulation During Hemodialysis With MCO PES-PVP (Theranova) Membrane

The purpose of the study is to compare the efficiency and biocompatibility of citrate and heparin anticoagulation during hemodialysis with medium cut-off polyarylethersulphone-polyvinylpirrolidone membrane (Theranova).

heparin
chronic haemodialysis
trisodium citrate
  • 13 views
  • 25 Jan, 2021
  • 1 location
Comparison of Biphozyl and Phoxilium as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH- Bicarbonate-levels and Respiratory Situation

The primary objectives of the BiPhox-Trial are to demonstrate, that the use of Biphozyl as a replacement fluid in adult critically ill acute kidney injury (AKI) patients, results in a lower rate of pH excursions and of bicarbonate (HCO3-) excursions compared to the use of Phoxilium during the studied continuous …

hemofiltration
critical illness
renal injury
  • 0 views
  • 25 Jan, 2021
  • 1 location
Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study

The purpose of this study is to evaluate the efficacy and safety of rivaroxaban for the prevention of deep vein thrombosis in patients with left iliac vein compression treated with stent implantation.

  • 0 views
  • 28 Jan, 2021
  • 9 locations